Table 1.
Patient characteristics based on indoleamine 2,3-dioxygenase (IDO1) expression in interstitial foci are detailed, with the average ± standard deviation data.
| Patient Attributes | IDO1 in Interstitial Foci IDO1-IF(+) Positive n = 80 |
IDO1 in Interstitial Foci IDO1-IF(−) Negative n = 41 |
p-Value |
|---|---|---|---|
| Recipient’s age at the time of transplantation (years) | 41.0 ± 14.71 | 43.83 ± 14.29 | 0.31 |
| Male gender (n, %) | 53 (66.25%) | 32 (78.0%) | 0.18 |
| Number of HLA 1 ABDR 2 mismatches |
3.51 ± 1.41 | 3.61 ± 1.13 | 0.711 |
| A | 1.27 ± 0.60 | 1.34 ± 0.47 | 0.53 |
| B | 1.37 ± 0.60 | 1.47 ± 0.54 | 0.37 |
| DR | 0.83 ± 0.52 | 0.84 ± 0.58 | 0.88 |
| Percentage of pre-sensitised patients | |||
| PRA 3 <10% | 33/45 (73.33%) | 23/33 (69.7%) | 0.72 |
| PRA 10–50% | 9/45 (20%) | 8/33 (24.24%) | 0.65 |
| PRA >50% | 3/45 (6.67%) | 2/33 (6.06%) | 0.91 |
| Cold ischemia time (hours) | 22.17 ± 7.79 | 22.03 ± 9.10 | 0.94 |
| Donor male gender (n, %) | 31/80 (38.75%) | 22/41 (53.66%) | 0.12 |
| Donor age (years) | 46.98 ± 16.08 | 50.0 ± 14.40 | 0.34 |
| Delayed graft function | 2/80 (2.5%) | 2/41 (4.88%) | 0.52 |
1 Human Leukocyte Antigen; 2 HLA-A, HLA-B (Class I) and HLA-DR (Class II)-specific classes of HLA genes; 3 Panel Reactive Antibody.